CoreAge Rx vs MyStart Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MyStart Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
MyStart Health
FDA warning letter, September 2025 — issued to Matthew Stern, CEO MyStart Health LLC.. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make MyStart Health a bad call — it's best for readers who want continuing clinical access and can confirm the named medication, payment cycle and cancellation cutoff before enrolling. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | MyStart Health |
|---|---|---|
| Brief Score | 94/100 (A) | 71/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm a named-drug quote Generic program starts at $299/mo; a current semaglutide quote is not established. Automatic billing depends on the selected plan. Full price detailsCurrent named semaglutide offer and complete quote unknown; generic program starts $299/month; earlier listing: From $299/mo (all doses, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm a named-drug quote Generic program starts at $299/mo; a current tirzepatide quote is not established. Automatic billing depends on the selected plan. Full price detailsCurrent named tirzepatide offer and complete quote unknown; generic program starts $299/month; earlier listing: From $299/mo (all doses, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Current medication-specific state availability requires confirmation; reviewed public pages did not establish a complete service roster |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
MyStart Health: The current program starts at $299/month before discounts, without verified separate medication quotes. Monthly or quarterly automatic billing depends on the selected plan.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.